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Abstract 
Enterotoxigenic Escherichia coli (ETEC) produces a variety of colonization factors necessary 
for attachment to the host cell, among which CS6 is one of the most prevalent in ETEC isolates 
from developing countries. The CS6 operon is composed of 4 genes, CssA, CssB, CssC, and 
CssD. The molecular mechanism of CS6 assembly and cell surface presentation, and the 
contribution of each protein to the attachment of the bacterium to intestinal cells remain unclear. 
In the present study, a series of css gene-deletion mutants of the CS6 operon were constructed in 
the ETEC genetic background, and their effect on adhesion to host cells and CS6 assembly was 
studied. Each subunit deletion resulted in a reduction in the adhesion to intestinal cells to the 
same level of laboratory E . coli strains, and this effect was restored by complementary plasmids, 
suggesting that the 4 proteins are necessary for CS6 expression. Bacterial cell fractionation and 
western blotting of the mutant strains suggested that the formation of a CssA–CssB–CssC 
complex is necessary for recognition by CssD and transport of CssA–CssB to the outer 
membrane as a colonization factor.  
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1. Introduction 
  Enterotoxigenic Escherichia coli (ETEC) is a major causative pathogen of infantile diarrhea in 
developing countries and traveler’s diarrhea in developed countries [1]. Especially in developing 
countries, ETEC is most frequently isolated from children younger than 5 years old with watery 
diarrhea. The World Health Organization estimated that there are more than 200 million cases of 
ETEC infection, resulting in nearly 380,000 deaths each year [2]. 
  ETEC strains produce several virulence factors such as heat-labile enterotoxin (LT), 
heat-stable enterotoxin (ST), and colonization factors (CFs) for the successful establishment of 
infections. Among these virulence factors, CFs are essential for adhering to small intestinal 
epithelial cells [3, 4]. To date, more than 25 CFs have been identified [5]. Epidemiological 
studies showed that CS6 is one of the most prevalent CFs [6-9], and it has therefore attracted 
attention as a target molecule for the development of an ETEC vaccine.  
  The CS6 operon consists of 4 genes, cssA, cssB, cssC, and cssD [10]. CssA and CssB are 
structural subunits, whereas CssC and CssD are estimated to be chaperone and usher, 
respectively, based on homology with known chaperone and usher proteins [10]. CssA binds to 
host cell fibronectin [11], while CssB binds to cell surface sulfatide [12]. Tobias et al. suggested 
that CssB is a key factor for binding to host cells and CssA inhibits CssB-mediated binding, and 
CssD is not involved in assembly or surface expression of CS6 based on findings obtained with 
laboratory strains in which the complete or deleted CS6 genes had been cloned and 
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overexpressed [13]. However, the molecular mechanisms of CS6 maturation in ETEC and 
attachment to intestinal cells are not fully understood, which is partly attributed to differences in 
the genetic background between laboratory E . coli strains and virulent ETEC strains. To gain 
insight into the mechanisms of CS6 maturation in ETEC and its role in binding to host cells, a 
series of deletion mutants of each gene in the CS6 operon was constructed within the genetic 
background of an ETEC clinical isolate in this study.  
 
2. Materials and Methods 
2.1. Bacterial strains and culture conditions 
  E . coli XLI-Blue, Top10 (Invitrogen, Carlsbad, CA) and DH5 were used for plasmid 
construction and maintenance. E . coli BL21 (DE3) was used for expression of recombinant 
proteins. These laboratory strains were grown in Luria–Bertani (LB) medium alone or with 
appropriate antibiotics at 37C. ETEC strain 4266, isolated from a patient with diarrhea from the 
National Institute of Cholera and Enteric Diseases, Kolkata, India [14], was used as a wild type 
(WT) control strain as well as a parental strain to construct isogenic CS6 mutant strains in this 
study. The ETEC strain and its derivatives were grown in CFA medium (1% Casamino acids, 
0.15% yeast extract, 0.05% MgSO4, 0.0005% MnCl2, pH 7.4) at 37C [15]. 
 
2.2. Construction of isogenic CS6 nonpolar mutants 
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  Isogenic mutants were obtained by the G-DOC system with modifications [16]. Briefly, the 
kanamycin (Km)-resistant gene cassette was amplified by PCR using primers containing the 
flanking regions of the css genes (Table 1) and pDOC-K as a template. The PCR product was 
cloned into the EcoRI site of pDOC-C vector. The resulting plasmid was transformed into the 
WT carrying helper plasmid pACBSce. The resulting colony was cultured for 3 hr in the 
presence of 0.5% of L-(+)-arabinose to induce lambda Red recombinase and I-SceI. The culture 
was then supplemented with sucrose to a concentration of 5%, incubated at 30C for 4 hr, spread 
on LB agar plates containing 5% sucrose and 30 g/mL Km, and incubated at 30C overnight. 
Mutants were obtained as Km-resistant and sucrose-insensitive colonies. The disruption of target 
genes was confirmed by PCR and DNA sequencing using the ABI PRISM 3100 genetic analyzer 
(Applied Biosystems, Foster City, CA).  
 
2.3. Construction of the CS6 complement vector 
  The region from 1.5 kb upstream of cssA to 1.5 kb downstream of cssD was amplified by PCR, 
using CS6-F and CS6-R as primers (Table 1). The amplified 7.1 kb CS6 gene-containing product 
was digested with SalI (TaKaRa-Bio, Kyoto, Japan) and cloned into the SalI site of pSTV28 
(TaKaRa-Bio) to yield pCS6 (Table 2). The CssA, CssB, CssC, 3FLAG-tagged CssC 
(CssC-FLAG), CssD, CssACD, and CssBCD expression plasmids were constructed by inverse 
PCR using the primers shown in Table 1 and pCS6 as a template. The 5 end of the primers was 
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phosphorylated by T4 polynucleotide kinase (TaKaRa-Bio) before being used for amplification. 
The PCR products were purified by Gene clean kit II (Qbiogenes, Irvine, CA) and ligated by T4 
DNA ligase (Invitrogen) at 16C overnight. The sequence of the resulting plasmids was 
confirmed by DNA sequencing using the ABI PRISM 3100 genetic analyzer (Applied 
Biosystems). Each plasmid was electrotransformed into mutants by using Gene Pulser (Bio-Rad 
Laboratories, Hercules, CA). 
 
2.4. Expression, purification , and preparation of antisera against CssA and CssB  
  The cssA and cssB genes were amplified by PCR using the primer set described in Table 1 and 
whole genomic DNA from WT strains as a template. The amplicons were cloned into the 
pET151-TOPO vector (Invitrogen) and transformed into BL21(DE3). The DNA sequence of the 
cloned genes was confirmed using the ABI PRISM 3100 genetic analyzer (Applied Biosystems). 
Each transformant was grown to OD600 = 0.8 and protein expression was induced with 0.1 mM 
IPTG for 3 hr at 25C. CssA was obtained as an inclusion body, whereas CssB was extracted 
from the soluble fraction. Recombinant proteins were purified using the HisBind kit (Merck, 
Darmstadt, Germany) according to the manufacturer’s protocol. Poly histidine-tag removal was 
achieved by TEV protease (Invitrogen) digestion. The resulting purified proteins were 
conjugated with Freund’s complete adjuvant and injected subcutaneously into rabbits 5 times at 
2-week intervals. One week after the last booster, the rabbits were sacrificed by 
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overanesthetization and the antiserum was isolated from whole blood. 
 
2.5. Reverse transcribed PC R (RT-PC R) 
  Total RNA extraction was performed as previously described [17] except that the MultiBeads 
shocker (Yasui Kikai, Osaka, Japan) was used at 1,500 rpm for 20 sec to destroy bacterial cells. 
Contaminating DNA was removed from total RNAs using the TURBO DNA-free kit (Ambion 
Inc., Austin, TX) according to the manufacturer’s protocol. Reverse transcription was performed 
using the Superscript III one-step RT-PCR kit (Invitrogen) according to the manufacturer’s 
protocol. The primers used to detect gene transcripts are listed in Table 1. 
 
2.6. Cell culture 
  The human colonic carcinoma cell line Caco-2 and the human embryonic intestinal cell line 
INT407 were grown in Eagle’s Minimum Essential Medium (MEM) (Gibco Laboratories, Grand 
Island, NY) supplemented with 10% fetal bovine serum (FBS) (Hyclone Laboratories, Logan, 
UT) at 37oC in 5% CO2. 
 
2.7. Adhesion assay 
  Bacteria were grown overnight in CFA alone or with the appropriate antibiotics diluted 1:10 
with CFA, and grown at 37C for 2 hr. After 3 washes with PBS and resuspension in MEM, the 
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bacteria were added to INT407 or Caco-2 monolayers in 24 well plates for a final concentration 
of 1  107 CFU/well. After 3 hr of incubation at 37C in 5% CO2, cells were washed 5 times with 
PBS and then lysed by 0.1% Triton X-100. Adhered bacteria were counted by serial dilution and 
plating of the lysate on LB agar.  
  
2.8. Preparation of the bacterial cell f raction 
  The bacterial culture was prepared using the adhesion assay described above. The bacteria 
were harvested by centrifugation at 10,000  g for 10 min, resuspended in 0.5 M sucrose, 5 mM 
EDTA, 50 mM Tris-HCl (pH 8.0), and incubated at 22C for 10 min. After centrifugation at 
10,000  g for 10 min, the pellet was suspended in ice-cold 5 mM MgSO4 and incubated on ice 
for 10 min. After centrifugation at 10,000  g for 10 min, the supernatant was stored as the 
“periplasmic fraction.” The pellet was resuspended in ice-cold 10 mM Tris-HCl (pH 8.0) and 
sonicated for 5 sec 8 times at 10 sec intervals on ice using the Handy Sonic UR-20P (TOMY 
SEIKO CO. LTD, Tokyo, Japan). The cell debris was removed by centrifugation at 10,000  g 
for 10 min and the supernatant was processed at 21,500  g for 2 hr. The supernatant was stored 
as the “cytosolic fraction,” and the pelleted “membrane fraction” was solubilized in 1  SDS 
sample buffer (50 mM Tris-HCl, pH 6.8, 2.5% 2-mercaptoethanol, 2% SDS, 0.01% BPB, and 
10% glycerol). All steps above were performed at 4C unless otherwise indicated. Bacterial cell 
fractions were kept at -30C until use. 
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2.9. Immunoprecipitation (IP) assay 
  pCssC-Flag was transformed into WT and cssA::Km strains. Whole cell extracts were 
collected from the transformants using Bugbuster HT (Merck) and the IP assay was performed 
using an anti-FLAG M2 affinity gel (Sigma-Aldrich Corp, St. Louis, MO), both according to the 
manufacturer’s protocols. IP complexes were suspended in 2 reductant-free SDS sample buffer 
(50 mM Tris-HCl, pH 6.8, 2% SDS, 0.01% BPB, 10% glycerol), and samples were kept at -30C 
until use.  
 
2.10. Western blot analysis 
  Samples were boiled for 5 min, separated by SDS-PAGE, and blotted to PVDF membranes 
(ATTO, Tokyo, Japan). CssA, CssB, and CssC-Flag were detected immunologically on PVDF 
membranes using an anti-CssA antiserum (1:2,500 dilution), anti-CssB (1:5,000 dilution) 
antiserum, and an anti-Flag M2 (SIGMA) monoclonal antibody (1:1,000 dilution) as primary 
antibodies. DnaK and RNA polymerase  subunit were detected by anti-DnaK (Assay Designs, 
Inc., Ann Arbor, MI) and anti-RNA polymerase  subunit (NeoClone Biotechnology 
International, Madison, WI) monoclonal antibodies, respectively. HRP-conjugated goat 
anti-rabbit IgG (Nacalai Tesque Inc., Kyoto, Japan) and anti-mouse IgG (Nacalai Tesque Inc.) 
were used as secondary antibodies in a dilution of 1:5,000. Target bands were visualized using 
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the Peroxidase Stain Kit for Immunoblotting (Nacalai Tesque Inc.). 
 
3. Results 
3.1. Construction of CS6 mutants 
  To elucidate the role of the CS6 gene, deletion mutants of each css gene (cssABCD) were 
generated using the G-DOC system [16] in an ETEC clinical isolate (Fig. 1A). Mutants were 
generated by replacement of each css gene with a Km-resistance gene (Kmr; ca. 1.3 kbp). 
Primers for PCR were designed from the flanking regions of Kmr insertion sites and used to 
amplify the css genes (Table 1). The PCR products of cssA, cssB, cssC, and cssD in WT were 
2,273, 989, 663, and 3,344 bp, respectively, whereas those of the mutants were 3,180, 1,859, 
1,518, and 2,421 bp, respectively (Fig. 1B). DNA sequencing of these mutant genes further 
confirmed that each open reading frame was successfully replaced by Kmr. 
  Because the css genes are transcribed from a single promoter [13], the possible presence of a 
polar effect in the CS6 operon within each mutant was tested. RT-PCR analysis of the mutant 
strains showed that downstream genes of the Kmr in the CS6 operon were transcribed at the same 
level as those of the WT strain (Fig. 1C). The mutants therefore did not show polar effects due to 
the integration of Kmr in the CS6 operon. 
 
3.2. CssA cannot exist alone in E T E C 
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  To analyze the expression of CS6 structural genes in the mutant strains, western blot analysis 
of total bacterial cell extracts was performed using anti-CssA and anti-CssB antisera. CssB was 
detected in all mutants except the cssB::Km strain, whereas CssA was not detected in the 
cssA::Km or in the cssB::Km strains (Fig. 4, whole cell extracts). To test whether this 
phenomenon was unique to ETEC, CssACD and CssBCD expression vectors were constructed 
and transformed into laboratory E . coli strain TOP10 and confirmed by western blotting. As 
shown in Fig. 2, CssA and CssB were expressed in TOP10 harboring pcssACD and pcssBCD, 
respectively. The expression level of CssB was the same in pcssBCD as in TOP10 harboring 
pCS6, whereas CssA was diminished in pcssACD as compared with TOP10 harboring pCS6 
(Fig. 2). The same result was obtained when the E . coli XL1-Blue strain was used as a 
transformation host (data not shown). These data indicated that stable expression of CssA is 
dependent on CssB but not vice versa, and CssA is more unstable in the ETEC genetic 
background than in laboratory strains. 
 
3.3. A ll css genes are necessary for maximal adhesion of E T E C to host cells 
  To analyze the role of the CS6 genes in host cell adhesion, we performed adhesion assays of 
CS6 mutants using the INT407 and Caco-2 human epithelial cell lines. The adhesion ability of 
all css mutants was significantly decreased in the INT407 and Caco-2 (Fig. 3A) lines. However, 
the adhesion capacity of the mutants was recovered by introduction of expression plasmids for 
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each gene (Fig. 3B). 
  Because the cssB::Km strain did not express CssB and CssA as indicated above, this assay 
was not sufficient to analyze the role of CssB upon adhesion to host cells. Recombinant CssA 
and native CssA can bind to host fibronectin equivalently [11]. Furthermore, CssA is expressed 
in the absence of CssB in TOP10 (Fig. 2). Therefore, adhesion assays were performed using 
TOP10 expressing CssACD, CssBCD, and CssABCD. As shown in Fig. 3C, the adhesion of the 
CssB-deleted strain was significantly reduced to the same level as that of the CssA-deleted strain 
and the TOP10 transformed with empty vector. Taken together, these data demonstrate that all 
css genes are required for maximal adhesion to host cells. 
 
3.4. Cellular distr ibution of CssA and CssB in CS6 mutant bacteria 
  The adhesion assay suggested that CS6 was not successfully expressed in all mutants. To 
assess the effect of each gene deletion on CS6 assembly, cell fractionation of all mutants and 
western blot analysis using anti-CssA and anti-CssB antisera were performed. As shown in Fig. 4, 
western blot analysis of the membrane-associated and periplasmic fractions showed similar 
CssA and CssB profiles to those of the whole cell extract. In the cytoplasmic fraction of each 
mutant, CssA and CssB were significantly reduced compared with the levels in the WT strain. 
Both CssA and CssB were detected in the supernatant of the WT strain but not in that of any of 
the mutant strains. 
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3.5. CssC interacts with CssB 
  To evaluate the role of CssC in CS6 maturation, strains expressing CssC-FLAG were 
generated and used for IP assays using whole cell extracts. INT407 cell adhesion assays using 
cssC::Km harboring pcssC-FLAG showed that the CssC-FLAG construct could fully 
complement the cssC::Km strain (Fig. 5A), suggesting that the 3FLAG did not interfere with 
the function of CssC. Whole cell lysates of WT, cssA::Km, WT pcssC-Flag, and cssA::Km 
pcssC-Flag were used in IP assays. As shown in Fig. 5B, CssA and CssB were precipitated by 
CssC-FLAG and the amount of precipitated CssB was diminished in the presence of CssA. 
These data suggested that both CssA–CssB and CssB alone can bind to CssC. 
 
4. Discussion 
  CS6 consists of 4 subunits and is thought to be assembled through a chaperone–usher pathway 
[10]. The CS6 subunits are encoded by the cssABCD genes as a single operon. To understand the 
intrinsic role of CS6 in the adherence of ETEC to host cells and the contribution of each subunit, 
we constructed isogenic CS6 mutants within the ETEC background.  
  Our results suggested that CssA requires CssB to exist stably in ETEC cells, while in 
laboratory strains, CssA was expressed alone, although at a lower frequency than in CS6 
expressing strains (Fig. 2). CssA has been suggested to be toxic for E . coli [13], which was 
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confirmed by the slow growth of CS6-expressing laboratory strains compared with strains 
carrying empty vectors, while the growth of ETEC4266 was not affected by the presence or 
absence of CS6 (data not shown). These results suggest that CssA itself is unstable in E . coli and 
that ETEC may possess a unique system to degrade CssA. Investigation of the potential 
ETEC-specific CssA-regulating mechanisms is currently taking place in our laboratory. 
  The mutants constructed in the present study revealed that all CS6 genes were required for 
maximal adhesion to intestinal cells (Fig. 3). The current results show discrepancies with a 
previous study using a laboratory E . coli strain overexpressing CS6 that reported that CssB and 
CssC are important for CS6 expression and cell adhesion ability is enhanced in the absence of 
CssA or of both CssC and CssD [13]. There are at least 2 possible explanations for these 
discrepancies. First, the genetic background of the ETEC strain differs from that of the 
laboratory strain with regard to the CS6 expression profile. The current results suggest that the 
instability of CssA is different in the WT ETEC and the laboratory strain. In addition, native CS6 
has been reported to have fatty acid modifications within the CssA subunit, which are not present 
in recombinant CS6 [11]. Second, the use of the CS6 native promoter and a low copy number 
plasmid in our CS6 expression analysis with laboratory strains likely resulted in a lower number 
of css gene transcripts compared with those obtained with an IPTG-inducible tac promoter. 
  The adhesion assay performed using complemented strains showed that the adhesion of 
cssC::Km complemented by pcssC and pcssC-Flag was significantly greater than that of the 
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WT strain (Fig. 3B, 5A), suggesting that complemented strains expressed more CS6 on the outer 
membrane than the WT strain. CFA/I, which is a well-studied ETEC colonization factor, is 
reported to contain a stem-loop structure between the cfaB major subunit and the cfaC usher 
subunit, and this stem-loop is responsible for both stabilization of cfaB mRNA and 
destabilization of its downstream mRNA [18]. In the present study, the mRNA level of cssC was 
lower than that of the other subunit genes (Fig. 1C), indicating that the stem-loop structure in the 
CS6 operon might function in a similar manner as that of the CFA/I operon. Moreover, these 
results also suggested that CssC regulates the level of CS6 expression on the outer membrane. 
  Cell fractionation analysis and IP assays showed that CssB alone could be targeted to the 
membrane without other subunits (Fig. 4) and CssB associates with CssC (Fig. 5) in ETEC cells. 
These results, together with the absence of CssA and CssB from the supernatant of mutant strains 
(Fig. 4), and the reduction in adhesion by the loss of any subunit (Fig. 2), indicate that CssB 
alone or the CssB–CssC complex are not transported to the cell surface through the outer 
membrane via CssD. The formation of a CssA–CssB–CssC complex is therefore assumed to be 
necessary for recognition by CssD and transport of the CssA–CssB complex through the outer 
membrane and for its exposure in a functionally active form. 
  This analysis also showed that the distribution of CS6 subunits is very low in the cytoplasmic 
fraction of all mutants (Fig. 4). In these mutants, the CS6 subunits are expected to accumulate in 
the periplasm if they cannot be transported outside, as discussed above. Uropathogenic E . coli 
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(UPEC) has a Cpx 2-component signal transduction system that is activated by misfolding or 
aggregation of pili subunits in the periplasm, resulting in the upregulation of DegP protease and 
the negative regulation of genes to alleviate the periplasmic stress [19, 20]. A similar feedback 
mechanism may operate in ETEC to regulate the expression of CS6. 
  On the basis of the present results, a CS6 assembly model was generated and is depicted in Fig. 
6. First, translated CS6 subunits are transferred to the periplasm, where CssA forms a complex 
with CssB and CssC. Meanwhile, free CssA is degraded by a system specific to ETEC. The 
CssA–CssB–CssC complex is recognized by CssD, and CssA–CssB is transported to the cell 
surface through the outer membrane, while the CssB–CssC complex cannot pass through the 
outer membrane. The accumulation of free subunits in the periplasm triggers the downregulation 
of CS6 genes by a feedback system that is still unknown. 
  In conclusion, the CS6 isogenic mutant strains, as well as CS6 recombinant strains, 
demonstrated that CssB is required for stabilization of CssA, and all css genes in the CS6 operon 
are necessary for maximal adhesion of ETEC to epithelial cells and CS6 assembly. Although 
CS6 is the most prevalent ETEC colonization factor isolated in developing countries [8, 9, 21], 
many aspects of the nature and function of CS6 remain to be elucidated. The present study 
provides a starting point for the understanding of CS6 maturation and function, particularly in 
the ETEC background, with the ultimate goal of developing a vaccine to target ETEC 
colonization factors in the near future. 
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Primer Sequence (5' to 3') Description
CssA-F AGAACAGAAATAGCGACTAA RT-PCR for cssA  gene, Confirmation of cssB- deleted mutant
CssA-R TTAGTTTACATAGTAACCAAC RT-PCR for cssA  gene, Confirmation of cssA- deleted mutant,
and Construction of pcssA and pcssB
CssB-F AGGAAACTGGCAATATAAAT RT-PCR for cssB  gene
CssB-R TTAATTGCTGTAAAATGATA RT-PCR for cssB  gene, Confirmation of cssB -deleted mutant,
and Construction of pcssB
CssC-101F ATTTACTCTGACAGCACACCATC RT-PCR for cssC  gene
CssC-611R TCTATTTTCTTCTCTGAGTATGG do.
CssD-392F ATATCAGCTTTGAGTTTAGCTCC RT-PCR for cssD  gene
CssD-3200R TAAGTTGCCCCCCAGTA do.
CS6-F TACCAGCCATCTTAGCTTAC Construction of pCS6
CS6-R GACAGAATCTGTCGACCTGAGTCTGAGGATGATCG do.
CssA-pET151F CACCAGAACAGAAATAGCGACTAA Construction of rCssA, rCssB expression plasmid
CssB-pET151F CACCGGAAACTGGCAATATAAATCTC do.
CssA-del-F AAAATGAATTCAGCAATAGTAATGGTGTTATATGAAGAAAACAATTGGTTTGACCGGTCAATTGGCTGGAG Construction of Km cassette for cssA -deletion
CssA-del-R TTTCAGAATTCTCATACTTCCAGTATTTAGTTTACATAGTAACCAACCATAAATATCCTCCTTAGTTCC do.
CssB-del-F AAAATGAATTCATACTGGAAGTATGATTATGTTGAAAAAAATTATTCCGGCGACCGGTCAATTGGCTGGAG Construction of Km cassette for cssB -deletion
CssB-del-R TTTCAGAATTCATAATGCGGCCTTTTTTTAATTGCTGTAAAATGATACAGTAATATCCTCCTTAGTTCC do.
CssC-del-F GACGAGAATTCCCAGGCAAAAATATGAAATCAAAGTTAATTATATTATTGAGACCGGTCAATTGGCTGGAG Construction of Km cassette for cssC- deletion
CssC-del-R TCTGAGAATTCAAAAACCTCAGAAAAGCTAATGTAATAGGGTGTATTATTTAATATCCTCCTTAGTTCC do.
CssD-del-F TATACGAATTCATCAGATTACAGACTTGCTTTTTTTTCTATTTCTATATCCGACCGGTCAATTGGCTGGAG Construction of Km cassette for cssD -deletion
CssD-del-R AATTCGAATTCAGATATATCTTTTTCTGAAAAAGGAAATGAACAGACTTTTAATATCCTCCTTAGTTCC do.
CssA-up-F ATCACCAGGTATTCTTCCCG Confirmation of cssA -deleted mutant
CssC-F-inverse ATGAAATCAAAGTTAATTATATTATTG Confirmation of cssC- deleted mutant, Construction of
pcssACD and pcssCD
CssC-R2 AAAAGCAAGTCTGTAATCTG Confirmation of cssC -deleted mutant
CssD-F ATGATGCTGGCGCAAAAAC Confirmation of cssD -deleted mutants
CssD-downR AGGTGAGCTGAGCTACAGC do.
CssB-F-inverse ATGTTGAAAAAAATTATTCCGG Construction of pcssBCD
Cs6-pro-R-inverse ATAACACCATTACTATTGCTATA Construction of pcssBCD, pcssCD and pcssD
CssD-F-inverse ATGATGCTGGCGCAAAAAC Construction of pcssD
Css-term F ACTTCCTGAGAAAGAGGTAAAC Construction of pcssA, pcssB and pcssC
CssC-R TTATAAAATTGATTCATAA Construction of pcssC
CssC-Flag-F ATGATATCGACTACAAAGATGACGACGATAAATAGTAAACTTCCTGAGAAAGAGGTAAAC Construction of Flag-tagged CssC expression plasmid 
CssC-Flag-R GATCTTTATAATCACCGTCATGGTCTTTGTAGTCTAAAATTGATTCATAAAGTTTTGTTT do.
Table 1. Oligonucleotide primers used in this study
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Plasmid name Description Source
pET151TOPO Expression vector, Ampr, pBR322ori Invitrogen
pETCssA cssA  without signal peptide cloned into pET151TOPO This study
pETCssB cssB  without signal peptide cloned into pET151TOPO This study
pSTV28 Cloning vecter, Cmr, p15Aori TaKaRa-Bio
pCS6 7 kb fragment containing CS6  cloned into pSTV28 This study
pcssACD CssACD expression plasmid derived from pCS6 This study
pcssBCD CssBCD expression plasmid derived from pCS6 This study
pcssCD CssCD expression plasmid derived from pCS6 This study
pcssA CssA expression plasmid derived from pcssACD This study
pcssB CssB expression plasmid derived from pcssBCD This study
pcssC CssC expression plasmid derived from pcssCD This study
pcssD CssD expression plasmid derived from pCS6 This study
pcssC-Flag CssC-3Flag expression plasmid derived from pcssCD This study
pACBSce Red recombinase and I-SceI expression plasmid, Cmr, p15Aori [16]
pDOC-K Template plasmid for G-DOC system, Kmr, Ampr, pMBIori , ori T [16]
pDOC-C Cloning plasmid for G-DOC system, Kmr, Ampr, pMBIori , ori T [16]
pDOC-CssA cssA  flanking region and Kmr cassette cloned into pDOC-C This study
pDOC-CssB cssB  flanking region and Kmr cassette cloned into pDOC-C This study
pDOC-CssC cssC  flanking region and Kmr cassette cloned into pDOC-C This study
pDOC-CssD cssD  flanking region and Kmr cassette cloned into pDOC-C This study
Table 2. Plasmids used in this study
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F igure captions 
Fig. 1.  
Construction of CS6 mutants . (A) CS6 genes in the ETEC strain 4266 (WT) and in each mutant. 
The mutants have a kanamycin-resistance gene (Kmr) insertion within each CS6 gene. (B) 
Confirmation of gene replacement in mutants by PCR. (C) RT-PCR analysis of CS6 gene 
transcripts in the mutants. PCR and RT-PCR were performed as described in the Materials and 
Methods section. A, cssA; B, cssB; C, cssC; D, cssD. 
 
Fig. 2. 
Western blot analysis of the CS6 structural subunits CssA and CssB in TOP10 and its derivatives. 
Equal amounts of whole cell extracts estimated by the OD600 of the culture were blotted onto 
PVDF membranes and immunostained with CssA or CssB antisera. Anti-DnaK antibody was 
used as a loading control.  
 
Fig. 3.  
Adhesion assay of the mutant strains in intestinal cells. The adherence of CS6 gene mutants 
including WT (A), complemented strains (B), and laboratory strain transformants (C) to INT407 
and Caco-2 cells is shown. Values indicate the mean  SE of viable bacteria bound to INT407 
cells or Caco-2 cells per well of a 24-well plate. The asterisks indicate significant differences in 
the number of adhered bacteria (P < 0.01 in A and C, P < 0.05 in B) from WT (A, B) or TOP10 
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pSTV28 (C) as judged by the Student’s t test. Assays were performed in triplicate on 2 different 
days. 
 
Fig. 4. 
Cell fractionation analysis of WT and mutants. WT and all mutants were fractionated as 
described in the Materials and Methods section. Each fraction was processed by SDS-PAGE and 
western blotting using anti-CssA and anti-CssB antisera. Fractions are indicated on the left. 
Anti-RNA polymerase  subunit and anti-DnaK monoclonal antibodies were used as internal 
controls.  
 
Fig. 5. 
Analysis of the function of CssC. (A) Adherence of WT, cssC::Km, and cssC::Km 
pcssC-FLAG to INT407. Values represent the mean  SE of viable bacteria bound to INT407 
cells per well of a 24-well plate. The asterisks indicate significant differences in the number of 
adhered bacteria (P < 0.01) from the WT strain as judged by the Student’s t test. These assays 
were performed in triplicate on 2 different days. (B) Co-immunoprecipitation between CssC and 
CssA or CssB. The IP complex and input of each sample were probed with anti-CssA antiserum, 
anti-CssB antiserum, and anti-FLAG M2 antibody. 
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Fig. 6. 
Schematic model of CS6 maturation. OM, outer membrane; PP, periplasm; IM, inner membrane; 
CP, cytoplasm; A, CssA; B, CssB; C, CssC; D, CssD; ?, unknown factors. 
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